Novel mosaic TRAF7 likely pathogenic variant in an African American family
- PMID: 37067385
- DOI: 10.1002/ajmg.a.63214
Novel mosaic TRAF7 likely pathogenic variant in an African American family
Abstract
Pathogenic variants in TRAF7 are often de novo and features of individuals harboring these variants are characterized by neurodevelopmental delay, ptosis, cardiac defects, limb anomalies, and dysmorphic features. We present a familial case in two African American patients with a novel, likely pathogenic c.1936G>A variant in TRAF7. Patient 1 is a 31-year-old female with a patent ductus arteriosus (PDA), intellectual disability, ptosis, and other dysmorphic features. She was identified to harbor this likely pathogenic variant in a mosaic (33.89%) state in leukocytes. Her son, Patient 2, is a 10-month-old male with a PDA, atrial septal defect, ptosis, developmental delay, history of feeding difficulties, congenital maxillary frenulum, and malrotation of the intestine. He has the same variant in a non-mosaic state. These cases demonstrate the variable expressivity observed with variants in TRAF7 within the same family and expand upon current understanding of mosaic TRAF7 variants. They also provide phenotypic data on genetic variation in individuals with African American ancestry, a population who has been underrepresented in the literature and may be less frequently referred to genetic specialists.
Keywords: TRAF7; autosomal dominant; de novo; mosaicism; neurodevelopmental delay.
© 2023 Wiley Periodicals LLC.
References
REFERENCES
-
- Accogli, A., Scala, M., Pavanello, M., Severino, M., Gandolfo, C., De Marco, P., Musacchia, F., Torella, A., Pinelli, M., Nigro, V., & Capra, V. (2020). Sinus pericranii, skull defects, and structural brain anomalies in TRAF7-related disorder. Birth Defects Research, 112(14), 1085-1092. https://doi.org/10.1002/bdr2.1711
-
- Ademuyiwa, F. O., Salyer, P., Ma, Y., Fisher, S., Colditz, G., Weilbaecher, K., & Bierut, L. J. (2019). Assessing the effectiveness of the National Comprehensive Cancer Network genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutations. Breast Cancer Research and Treatment, 178(1), 151-159. https://doi.org/10.1007/s10549-019-05359-w
-
- Bouwmeester, T., Bauch, A., Ruffner, H., Angrand, P.-O., Bergamini, G., Croughton, K., Cruciat, C., Eberhard, D., Gagneur, J., Ghidelli, S., Hopf, C., Huhse, B., Mangano, R., Michon, A.-M., Schirle, M., Schlegl, J., Schwab, M., Stein, M. A., Bauer, A., … Superti-Furga, G. (2004). A physical and functional map of the human TNF-alpha/NF-kappa-B signal transduction pathway. Nature Cell Biology, 6, 97-105.
-
- Castilla-Vallmanya, L., Selmer, K. K., Dimartino, C., Rabionet, R., Blanco-Sánchez, B., Yang, S., Reijnders, M., van Essen, A. J., Oufadem, M., Vigeland, M. D., Stadheim, B., Houge, G., Cox, H., Kingston, H., Clayton-Smith, J., Innis, J. W., Iascone, M., Cereda, A., Gabbiadini, S., … Gordon, C. T. (2020). Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7. Genetics in Medicine, 22(7), 1215-1226. https://doi.org/10.1038/s41436-020-0792-7
-
- Khan, A., Rogers, C. R., Kennedy, C. D., Lopez, A., & Jeter, J. (2022). Genetic evaluation for hereditary cancer syndromes among African Americans: A critical review. The Oncologist, 27(4), 285-291. https://doi.org/10.1093/oncolo/oyab082
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases